Challenges | No. = 300, 100% | |
---|---|---|
Lack of trust in the quality of the compounded formulations | 147 (49) | |
Belief that compounded formulations have poor patient compliance | 122 (40.7) | |
Compounded prescriptions are inconvenient economically | 49 (16.3) | |
Belief that the ministry of health does not allow compounded formulations | 33 (11) | |
not adequate | skilled personnel | 49 (16.3) |
manufacturing environment | 80 (26.7) | |
no ingredients | 50 (16.7) | |
Fear of inappropriate use (overuse or underuse) | 67 (22.3) | |
Fear of AMR development | 73 (24.3) | |
other (specify) | 3 (1) |